News & EventsResourcesCareersInvestors

Webinars, Pharmaceutical

Supporting Earlier Delivery-System Decisions Through a USP <382>-Aligned Approach

8 Sep 2026

Early delivery-system decisions can influence the success of injectable drug development programs. This article explores a USP <382>-aligned system-level approach developed by Aptar Pharma and Stevanato Group, evaluating prefilled syringe, plunger, and rigid needle shield configurations to generate performance and integrity

By: Crystal Salvans, Aptar Pharma Sara Masucci, Stevanato Group

Share

8 Sep 2026

Two prefilled syringe configurations illustrating a USP <382>-aligned system-level approach for delivery system development

Learn more about Aptar Pharma Expertise
in Injectable Drug Delivery

Find Out More About Injectable Drug Delivery

This Might Also Be of Interest

Aptar Pharma x Dianosic: Innovating Intranasal Drug Delivery

Pharmaceutical Webinars

NeuroSpray™: Precision Nose-to-Brain Drug Delivery Platform

Pharmaceutical Publications

Overcoming Challenges in Preclinical Studies for Intranasal and Inhalation Programs

Pharmaceutical Webinars

Optimising Preclinical Studies for Intranasal and Pulmonary Programmes

Pharmaceutical Publications

injectable contamination control strategy glp-1 stoppers pre-filled syringe

Subscribe to Email Updates

Submit your email address below and stay up to date with the latest industry insights.

*Required. For details about how your email address will be used, read our General Terms and Conditions, Privacy and Cookies Policy.